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INTRODUCTION
Giardiasis is a gastrointestinal disease caused by Giardia lam-
blia, an extracellular protozoan [1]. This pathogen is ingested 
as an infective cyst, which is converted into trophozoites in the 
small intestine of the host. The resulting trophozoites are pres-
ent either as free/swimming or attached to the surface of the 
epithelium, without invading the tissue. A distinct pathology 
of chronic giardiasis is shortening of the intestinal villi of the 
infected host [2]. Therefore, the mechanism by which these 
extracellular trophozoites trigger immune responses in the 
gastrointestinal tract of the host has been a subject of interest.
Diverse innate immune responses are activated in the small 
intestine infected with Giardia, which includes production of 
antimicrobial peptides [3], and nitric oxide (NO) [4] by intes-
tinal epithelial cells. Interestingly, G. lamblia trophozoite has a 
strategy to evade the NO-mediated killing by actively utilizing 
arginine, a substrate for NO production [5]. Several cytokines 
had been reported to be up-regulated during Giardia infection, 
which include IL-6 [6], IL-17, IFN-γ, tumor necrosis factor-α 
and others. Especially, an in vitro stimulation of the host cells 
with Giardia extracts, induced release of IL-17 [7]. An in vivo 
infection model, using cattle, indicated a proliferation of IL-
17-producing CD4+ T-cells [8]. Activation of IL-17-producing 
memory CD4+ T-cell was also demonstrated in G. lamblia in-
fection in humans [9]. Role of IL-17 in Giardia clearance was 
proven using IL-17 receptor A (IL17RA) knockout (KO) mice 
[10]. Comparative microarray analysis of wildtype versus IL-
17RA KO mice provided information on IL-17 function in 
Giardia clearance, which included production of antimicrobial 
peptides and complement factors [11].
Gastrointestinal tract is the complex system which is con-
stantly exposed to various exogenous organisms, diverse anti-
gens, and ligands, not to mention with the normal microflora. 
Therefore, this system is required to maintain homeostasis and 
immune tolerance via complex and pleiotropic interactions 
among the epithelial and immune cells. Among them, the in-
nate immune cells lacking specific antigenic receptors can be 
divided into myeloid cells and ILCs. In contrast to myeloid 
cells expressing pattern recognition receptors, ILCs are small 
molecule, like T-cell or B-cells, but lacking antigenic receptors. 
Therefore, ILCs response directly to cytokine from both my-
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Abstract: Innate lymphoid cells (ILCs) are key players during an immune response at the mucosal surfaces, such as lung, 
skin, and gastrointestinal tract. Giardia lamblia is an extracellular protozoan pathogen that inhabits the human small intes-
tine. In this study, ILCs prepared from the lamina propria of mouse small intestine were incubated with G. lamblia tropho-
zoites. Transcriptional changes in G. lamblia-exposed ILCs resulted in identification of activation of several immune path-
ways. Secretion of interleukin (IL)-17A, IL-17F, IL-1β, and interferon-γ was increased, whereas levels of IL-13, IL-5, and IL-
22, was maintained or reduced upon exposure to G. lamblia. Goup 3 ILC (ILC3) was found to be dominant amongst the 
ILCs, and increased significantly upon co-cultivation with G. lamblia trophozoites. Oral inoculation of G. lamblia trophozo-
ites into mice resulted in their presence in the small intestine, of which, the highest number of parasites was detected at 
the 5 days-post infection. Increased ILC3 was observed amongst the ILC population at the 5 days-post infection. These 
findings indicate that ILC3 from the lamina propria secretes IL-17 in response to G. lamblia, leading to the intestinal pa-
thology observed in giardiasis.
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eloid cells and non-immune cells (such as epithelial cells), 
and transmit the information to other immune cells such as 
dendritic cells (DCs), T-cells or B-cells, eventually establishing 
both innate and adaptive responses in the hosts [12].
In this study, ILCs were isolated from the murine small in-
testine, and stimulated with Giardia trophozoites in culture 
plates containing transwell membranes. Comparative tran-
scriptome analysis provided information on up-regulated 
genes of murine ILCs by G. lamblia, including diverse compo-
nents of the immune response, one amongst which was the 
IL-17 pathway. By monitoring marker cytokines, the ILC group 
involved in G. lamblia-induced immune response, was deter-
mined via both in vitro and in vivo infection assays.
MATERIALS AND METHODS
Cultivation of G. lamblia
Trophozoites of G. lamblia GS strain (ATCC #50581, ATCC, 
Manassas, Virginia, USA) were grown under axenic conditions 
in a TYI-S-33 medium (2% casein digest, 1% yeast extract, 1% 
glucose, 0.2% NaCl, 0.2% L-cysteine, 0.02% ascorbic acid, 
0.2% K2HPO4, 0.06% KH2PO4, 10% calf serum, and 0.5 mg/ml 
bovine bile, pH 7.1) [13] at 37˚C.
Mice
C57BL/6 mice (6 week-old) were purchased from OrientBio 
Co. (Seongnam, Korea), and maintained at the animal facility 
of Yonsei University College of Medicine under SPF condi-
tions. All experiments were approved by the Yonsei University 
College of Medicine Ethics Committee (IACUC 2017-0015).
Isolation of innate lymphoid cells
Mouse ILCs were prepared as described [14]. Briefly, the 
small intestines were extracted from C57BL/6 mice. After re-
moval of the surrounding mesentery and Peyer’s patches, and 
fecal matters, the small intestines were minced into longitudi-
nal pieces of 7 cm, and further cut into 1 cm pieces, followed 
by vigorous washes in phosphate buffered saline (PBS: 137 mM 
NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, and 2 mM KH2PO4, 
pH 7.4). They were further treated with 1 mM EDTA/PBS at 
37˚C for 20 min for removal of the intraepithelial lymphocyte 
and intestinal epithelial cell fractions. Thereafter, the samples 
were harvested by centrifuging for 20 min at 500×g, followed 
by vigorous washing for 20 sec in PBS. Further, they were 
minced into 1-2 mm pieces, and incubated in 10 ml of pre-
warmed RPMI medium supplemented with 2% fetal bovine 
serum containing 20 µg/ml Liberase DH (Roche, Basel, Swit-
zerland) and 50 µg/ml DNase I (Roche) at 37˚C for 30 min. 
The cells were subsequently passed through a 70 µm EASY 
strainer (BD Biosciences, San Jose, California, USA), and a 37 
µm nylon filter (BD Biosciences). The flow-through cells were 
harvested by centrifuging for 5 min at 500×g, 4˚C, and then 
used as an ILC fraction.
ILC activation with G. lamblia tophozoites
ILCs (1×106 cells per well) were seeded in a 24 well culture 
plate with transwell membranes (Merck, USA) and incubated 
for 6 hr for RNA preparation and 16 hr for cytokine determi-
nation, with G. lamblia having multiplicity of infection (MOI) 
of 5. The culture media were collected for cytokine determina-
tion, and the ILCs were harvested for RNA preparation.
RNA isolation and expression analysis in RNA-sequence
RNAs were prepared from 4 independent ILC preparations, 
incubated with G. lamblia, and 4 control ILCs (ILCs only) us-
ing TRIzol (Invitrogen Life Technologies, Carlsbad, California, 
USA), and then treated with the RNase-free DNase (Qiagen, 
Valencia, California, USA) according to the manufacturer’s in-
structions. These RNA samples were submitted to Macrogen 
(Seoul, Korea) for RNA sequencing by HiSeq4000 (Illumina 
Inc., San Diego, California, USA). The resulting sequences 
were mapped against the genomic DNA reference (UCSC 
mm10) using HISAT2 program (Johns Hopkins University, 
USA). After alignment, the relative abundance of the tran-
scripts was measured with the String Tie software (Johns Hop-
kins University), which measures abundance of each transcript 
as FPKM (Fragments Per Kilobase of transcript per Million 
mapped reads). The 4 samples for each group (ILCs alone or 
ILC incubated with G. lamblia) were analyzed as a cluster to 
monitor similarity within the group. The numbers of clusters 
were independently assessed using Hierachical clustering anal-
ysis (Euclidean method, Complete Linkage) to construct a 
heat map. Differentially expressed transcripts were annotated 
and automatically categorized using KEGG pathway analysis 
program (http://www.kegg.jp/kegg/pathway.html). The gener-
ated in the RNA-seq is available at the Gene Expression Omni-
bus (GEO) database with the accession number GSE130256.
Enzyme-linked immunoassay (ELISA)
Culture media from the ILCs incubated with G. lamblia, 
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were used for detection of IL-17A, IL-17F, IL-22, IFN-γ, IL-1β, 
IL-5, and IL-13, by a sandwich ELISA to detecting IL-17A, as 
recommended by the manufacturer (BD Biosciences). The cul-
ture media collected from the ILCs, not exposed to G. lamblia, 
were used as controls for the assay.
Quantitative real-time PCR (qRT-PCR)
cDNA was synthesized from 4 µg of RNA using Prime-Script 
RT reagent kit (TaKaRa, Otsu, Japan) as directed by the manu-
facturer. The cDNAs were analyzed by qRT-PCR on a Light Cy-
cler 480 II real-time PCR system (Roche Applied Science, 
Mannheim, Germany) using Light Cycler 480 DNA SYBR 
green I master kit (Roche Applied Science). The amount of 
each transcript was estimated using specific pair of primers; 
GAPDH, IL-17A, IL-17F, IL-22, IFN-γ, IL-1β, IL-5, and IL-13. 
The primers were made as suggested [15]. GAPDH gene was 
used as an internal control to normalize each transcript. Data 
analysis was based on the relative quantification method by 
determining the crossing point (Cp) value using the Light Cy-
cler 480 II real-time PCR system software program (Roche Ap-
plied Science, version LSC480 1.5.0.39).
FACS 
The collected ILCs were analyzed using the live/dead fixable 
dead cell stain kit (Invitrogen, Carlsbad, California, USA) to 
determine the percentage of dead (stained) cells. The process 
was followed by manufacturer’s instruction. Briefly, cells were 
pre-treated with anti-CD16/CD32 antibodies, and then cells 
were incubated with the following antibodies: FITC-conjugat-
ed anti-mouse Lineage negative (Lin-), AlexaFluor 700-conju-
gated anti-CD103, phycoerythrin (PE)-conjugated anti-IL-25R, 
allophycocyanin (APC)-conjugated anti-mouse I-A/I-E (MHC 
class II), AlexaFluor 700-conjugated anti-IL-17A or relevant 
isotype control antibodies in FACS buffer (PBS, 1% BSA, and 
0.1% sodium azide). Fluorescence was measured by flow cy-
tometry, and data were analyzed using FlowJo data analysis 
software (TreeStar, Ashland, Oregon, USA). All antibodies 
were from eBioscience (San Diego, California, USA) unless 
stated otherwise.
Mice infection with G. lamblia trophozoites
Each C57BL/6 mouse was infected orally with 5×105 G. 
lamblia trophozoites. Similarly, control mice were orally inocu-
lated with 0.1 ml PBS, without G. lamblia trophozoites. The 
mice were sacrificed at various time-points, from 1 to 11 days 
post-infection (n=10), and their intestinal samples were col-
lected for experimental purpose. Sections of duodenum paraf-
fin blocks were stained with hematoxylin and eosin (H&E) 
and observed under Axiovert 200 fluorescence microscope 
(Carl Zeiss, Jena, Germany). 
In addition, 10 mice were orally infected with G. lamblia as 
described, and their small intestines were removed at 5 days 
post-infection. The same number of control mice were necrop-
sied and pooled as one group at the end of the trial. The small 
intestines obtained from mice of both groups were used to 
isolate ILCs as described above. These ILCs were analyzed for 
specific markers of the ILC group, using flow cytometry.
Statistical analysis
Results are expressed as means± standard deviations of 3 in-
dependent experiments. Data were analyzed by pair-wise com-
parison using Student’s t-test (SYSTAT program, SigmaPlot ver-
sion 9; Systat Software Inc., Chicago, Illinois, USA). Differenc-
es were considered significant if the P-value was<0.05. Data 
with P-value<0.01 are indicated with 2 asterisks, and data 
with P-values between 0.01 and 0.05 are indicated by a single 
asterisk.
RESULTS
Up-regulation of IL-17 signal pathway genes in the ILCs 
by G. lamblia
The gene expression profiles were compared between ILCs 
stimulated with G. lamblia and control ILCs, using RNA-seq. 
For each group, 4 samples were analyzed, and their similarity 
within the group was monitored (Fig. 1A). Except one sample 
of ILC group stimulated with G. lamblia, the one-way Hierar-
chical Clustering analyses indicated valid tendency in the gene 
expression profile within the group. By applying strict selec-
tion of FPKM, i.e., P-values<0.05 and fold change >2 for all 
genes, 472 genes were found to be up-regulated and 498 genes 
were found to be down-regulated in the ILC group stimulated 
with G. lamblia (Fig. 1B). These genes were categorized 16 
groups, according to their putative functions, which were pre-
sented as percentages of all the up- and down regulated genes 
(Fig. 1C). Substantial number of genes showing altered expres-
sion encoded hypothetical proteins (20-23%) and metabolic 
enzymes (9-13%) in both groups (up- and down-regulated 
clones). Eight to eleven percentage of up- and down-regulated 
genes were found to be involved in immune response, respec-
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Fig. 1. An RNA sequence analysis on the ILCs stimulated with G. lamblia. (A) Heat map across all the samples using the FPKM between 
the control ILCs and ILCs obtained after G. lamblia stimulation. Differentially expressed genes were sorted based on magnitude and sign 
of their t-statistics. (B) Number of up-, and down-regulated genes in ILCs incubated with G. lamblia with fold change more than 2 and 
P<0.05. (C) Diagrams showing the percentages of the up- or down-regulated genes in ILCs incubated with G. lamblia, categorized into 
their putative functions. 
A 
B 
C 
Fig. 2. Cytokine profiles of ILCs incubated with G. 
lamblia. (A) Cell-free supernatants were collected 
and assayed using ELISA kits. (B) Quantitative 
measurement of transcripts of cytokine genes. 
GAPDH was used as an internal control to nor-
malize each transcript. *0.01 <P <0.05, and 
**P<0.01 (Student’s t-test).  
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tively. In addition, the expression of signaling genes (10-20%) 
was found altered in the ILC group stimulated with G. lamblia. 
Interestingly, in this group, more cell cycle-related genes (15%) 
was found to be down-regulated (15%) rather than up-regu-
lated (3%).
Especially, regulation of signature genes for diverse immune 
response was found among the modulated genes in these 
RNA-seq data. As expected, several signaling pathways seemed 
to be activated, which included chemokine signaling, MAPK 
signaling, Jak-STAT, PI3K-Akt, the Rap1 signaling pathways. In 
addition, the data suggested activation of several immune path-
ways, cytokine-cytokine receptor interaction, intestine immune 
response for IgA production, Th17 differentiation, Th1/Th2 
differentiation, and IL-17 signaling pathway. Among the vari-
ous pathways found to be activated by G. lamblia, we focused 
on the signaling pathway for IL-17, which has been earlier re-
ported as a main regulator for immune response against G. 
lamblia [12].
Induction of IL-17 pathway related cytokines in vitro in 
the ILCs stimulated with G. lamblia 
In this experiment, ILCs were incubated with G. lamblia in 
plates containing transwell membranes and examined for the 
secretion of the following cytokines: IFN-γ, IL-1β, IL-5, IL-13, 
IL-17A, IL-17F, and IL-22 (Fig. 2A). Secretion of IFN-γ, IL-1β, 
IL-17A, and IL-17F was found to be significantly increased. 
While there was moderate increase in IFN-γ, IL-1β, and IL-17F 
(2.5- to 3.5-fold), more than 15-fold increase in IL-17A secre-
tion was observed. Secretion of IL-5, IL-13, and IL-22 was ei-
ther decreased or not affected by G. lamblia.
These data on cytokine secretion from ILCs stimulated with 
Giardia, were verified by qRT-PCR (Fig. 2B). Among the 7 cyto-
kine genes, only the IL-17A and IL-17F transcripts showed a 
significant increase (2.4- and 2.7-fold). Moderate increase in 
the transcript of IFN-γ, IL-1β, and IL-22 was observed (1.4- to 
1.7-fold). Decrease in the levels of IL-5 and IL-13 transcripts 
was noted.
Increase of ILC3 differentiation in vitro co-cultivation with 
G. lamblia
ILCs were divided into 3 groups: group 1 ILCs, group 2 ILCs, 
and group 3 ILCs, based on their cytokine production patterns 
that correspond to the helper T cell subsets, Th1, Th2, and 
Th17, respectively [12]. To determine which group of ILCs 
plays a role in G. lamblia-induced immune response, prepared 
murine ILCs were treated with Giardia, and assayed for expres-
sion of ILC markers using flow cytometry (Fig. 3A). In case of 
control cells, ILCs without G. lamblia stimulation, only a small 
portion of cells (0.02-0.3%) were stained with ILC1 (CD103) 
or ILC2 marker (IL-25R). The expression of these markers was 
increased to 0.2-2.3% when ILCs were stimulated with G. lam-
blia. Without G. lamblia stimulation, a significant portion of 
ILCs (25%) were stained with MHCII, an ILC3 marker. Expres-
sion of this surface protein was further increased to 53% when 
ILCs were incubated with G. lamblia. Along with IL-17 produc-
tion, the FASC analysis indicated that among the 3 ILC groups, 
ILC3 played the most important role in G. lamblia-induced 
immune response.
Therefore, increase of ILC3 in G. lamblia-treated cells was 
demonstrated by FACS analysis using MHCII and IL-17A, mark-
ers for ILC3 (Fig. 3B). Co-expression of these 2 proteins was ob-
served in only 15% of the control cells (ILCs untreated with G. 
lamblia), while in 46% of ILCs stimulated with G. lamblia.
Fig. 3. The activated group ILCs in the cells treated with G. lamblia in vitro. (A) Bar graph showing  percentage of ILCs stained with 
markers for 3 group ILCs. (B) Bar graph showing percentage of cells expressing 2 ILC3 markers analyzed by FACS. *0.01<P<0.05, 
and **P<0.01 (Student’s t-test).
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Increase of ILC3 differentiation in mice infectedwith  
G. lamblia
Role of ILC3 in G. lamblia-induced cytokine production was 
examined in vivo using a mouse model. Since mice are not 
natural hosts for G. lamblia, infection by G. lamblia trophozo-
ites was monitored for 11 days. Small intestines of the infected 
mice were extracted and prepared for H&E staining for observa-
tion of G. lamblia trophozoites, using microscopy (Fig. 4A). On 
the first day, few trophozoites were found in the murine intes-
tine. Maximal number of Giardia trophozoites was observed on 
the 5th day post-infection, and their presence gradually de-
creased, till no trophozoite was observed on days 10 and 11.
Based on the infection kinetics of mice with G. lamblia, ILCs 
were prepared from the mice infected with G. lamblia, at 5 days 
post-infection, and the 3 groups of ILCs were studied using flow 
cytometry (Fig. 4B). Less than 1% of the cells (0.11%) were 
stained, either with ILC1 or ILC2 marker, in the control ILCs, 
isolated from the uninfected mice. ILCs obtained from G. lam-
blia-infected mice showed 1.9% and 0.2% staining for ILC1 and 
ILC2, respectively. Corroborating with our in vitro data, more 
ILCs were stained with the ILC3 marker, both from the unin-
fected mice (35%) as well as from the G. lamblia-infected mice. 
However, the percentage of the ILC3-positive cells increased to 
66% in the ILCs isolated from mice infected with G. lamblia, in-
dicating a role of ILC3 in G. lamblia-induced immune response, 
which occurred in intestine of the infected mice.
DISCUSSION
The gastrointestinal tract is the primary site where G. lamblia 
initiates its infection. Among the various cells present in the 
small intestine, the ILCs were specifically studied to investigate 
how they modulate the immune response and adapt to G. 
lamblia trophozoites. Murine ILCs were prepared and chal-
lenged with G. lamblia trophozoites in vitro, resulting in death 
of ILCs (data not shown). Thus, ILCs were incubated with 
Giardia trophozoites in the presence of a membrane, such that 
only excretory-secretory products (ESPs) of Giardia could reach 
the ILCs, without inducing any cytotoxicity against them.
Transcriptional changes were monitored at the genomic lev-
el by comparative RNA-seq analysis of ILCs versus ILCs treated 
with Giardia ESPs (Fig. 1). For each group, 4 independent RNA 
samples were analyzed. All of 4 control samples (ILCs) dem-
onstrated a meaningful consistency in the expression level of 
the whole genomes, whereas only 3 RNAs derived from ILCs 
with Giardia exposure showed similar pattern of gene expres-
sion. When both up-regulated and down-regulated genes were 
categorized by their putative function (Fig. 1C), significant 
numbers of regulated genes (8-11%, and 10-20%) were found 
to encode immune regulators, and components of signaling 
pathways, respectively, as expected from function of the ILCs. 
Based on transcriptional changes of the cytokines, chemokines, 
and their cognate receptors in ILCs [16], we could speculate 
that Th1, but not Th2, differentiation occurred in ILCs exposed 
to Giardia. However, more elaborate RNA-seq data should be 
Fig. 4. Activated group ILCs in the small intestine of mice infected with G. 
lamblia. (A) Small intestine of mice infected with G. lamblia. Arrowhead in-
dicates G. lamblia trophozoites on the intestinal villi. PI; post-infection. 
Scale bar=50 µm. (B) Bar graph showing percentage of ILCs stained with 
markers for 3 group ILCs analyzed by FACS. *0.01 <P <0.05, and 
**P<0.01 (Student’s t-test).
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obtained from ILCs incubated with Giardia for various time-
points in order to draw a conclusion in this hypothesis.
Interestingly, the RNA-seq data revealed that the expression 
of numerous cell-cycle related genes (15% of the down-regu-
lated genes) were decreased in ILCs incubated with Giardia. 
This result indicates that even though Giardia ESPs did not in-
duce death of ILCs, they certainly altered the normal process 
of cell cycle of the ILCs.
Among candidate pathways activated in ILCs stimulated with 
Giardia, we noticed the IL-17 signaling pathway, of which thir-
teen signature components are found to be regulated. IL-17 is a 
well-known marker cytokine for group 3 ILCs [17], and has 
been reported as a pro-inflammatory cytokine involved in 
Giardia-induced immune responses [18]. Marker cytokines for 
ILC1 and ILC3 were detected by ELISA in the supernatants re-
leased from ILCs with Giardia (Fig. 2A). Among the 3 ILC3 cy-
tokines, IL-22 was not detected in ILCs stimulated with Giardia, 
contradicting a previous study, reporting that most of the ILC3 
cells (both Np46+ and Np46-) produced IL-22 [19]. However, 
increased il-22 gene transcripts were detected by qRT-PCR (Fig. 
2B). In this assay, all the ILC1 and ILC3 marker genes showed 
elevated transcript levels in the ILCs challenged with G. lamblia. 
On the contrary, 2 ILC2 markers, IL-5 and IL-13, did not show 
any up-regulation in this group via both ELISA as well as qRT-
PCR. These data suggest that ILC2 is not the main group ILC 
responsible for Giardia-induced immune response.
An assay to monitor relative expression of ILC surface mark-
ers (Fig. 3) clearly demonstrated that the ILC fraction prepared 
in this study had more ILC3 than ILC1 and ILC2. Abundance 
of ILC3 in the gastrointestinal tract has been reported in mice 
[20]. On the contrary, ILC2 are normally known to reside in 
the lungs of naïve animals [21]. Even though all 3 ILCs were 
found to be increased upon exposure to G. lamblia, significant 
increase of the ILC3 (46-53%) population was observed in the 
ILCs treated with Giardia, as shown in experiments using sin-
gle- and double-staining of ILC3 markers. Based on previous 
studies that have shown that ILC3 can modulate CD4+ T-cell 
responses through antigen (Ag)-peptide presentation by MHC 
class II [12,22], it is hypothesized that ILC3- and MHCII-de-
pendent mechanism is also involved in the adaptive host im-
mune responses to G. lamblia.
To examine whether ILC3 activation observed in the in vitro 
assays using ILCs, actually occurs in vivo during G. lamblia in-
fection, G. lamblia trophozoites were orally inoculated into 
mice, and the infection was monitored (Fig. 4A). Since mice 
are not natural hosts for G. lamblia, the infection did not result 
in shedding of Giardia cysts, and therefore, was monitored by 
observing the presence of Giardia trophozoites in the small in-
testine. As reported by other groups [10], the highest number 
of trophozoites was observed at day 5, and decreased thereaf-
ter. ILCs prepared from infected intestine at day 5 showed in-
creased expression of ILC3 marker, corroborating the findings 
of our in vitro experiments (Fig. 4B).
These results suggest a role of ILC3 in G. lamblia-induced 
immune response in the small intestine of the host. Previous 
reports have indicated an important function for ILC3 in regu-
lating interaction between the gastrointestinal tract and patho-
gens such as Citrobacter rodentium [23]. On the contrary, ILC2 
was found to be responsible for the immune response against 
helminths and lung diseases, such as asthma [24].
The function of ILC3 in G. lamblia-triggered immune re-
sponse in the gastrointestinal tract is complex and challenging 
to decipher, requiring elaborate investigations on the function 
of multiple immune and intestinal epithelial cells, as well as 
crosstalks among them. For example, in mice having ILC3 
with impaired MHC class II, both Ag-specific T-cell and T-de-
pendent B-cell responses were affected, showing that ILC3 
plays a role in Ag presentation to CD4+ T-cells in vivo [25]. In 
addition, lymphotoxin-activated ILC3 was shown to modulate 
T-cell independent IgA induction via NO production by 
CD11c+ DCs [26]. Therefore, ILCs may have a critical role not 
only in modulating cytokine-mediated epithelial cell barrier 
integrity, but also in regulating adaptive immune cells. Future 
studies should focus on downstream cells of ILC3 and their ef-
fect on the immune response against G. lamblia.
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